What Happened?
, -based Lyell Promoted Peter Tran as Director, Corporate Finance and Business
About the Company
We are entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. While enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. Cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers. Our goal is nothing less than to develop curative cell-based therapies for solid tumor cancers.
About the Person
Peter Tran is Director, Corporate Finance and Business at Lyell. Previously, Peter held various senior HR leadership roles in the industry.
Info Source
News
Short Profile